TRAF5 and hepatocellular carcinoma: To further ascertain whether TRAF5 knockdown could inhibit the NF-κB signaling in HCC cells, HepG2 cells were stably transfected with sh-NC or sh-TRAF5 and the NF-κB pathway was further analyzed.